Biological Technologies Office
Catherine Campbell, Ph.D., was named the deputy director of the Biological Technologies Office in August 2026. She joined DARPA as a program manager in January 2022.
During her tenure at DARPA, Campbell has focused on leveraging advanced biotechnology to safeguard military personnel and assets in harsh operational environments, enhance environmental resilience, accelerate the discovery of medical countermeasures, study both human and animal models of disease, and secure biological supply chains.
Prior to coming to DARPA, Campbell designed informatics systems for government biodefense applications, facilitated in silico identification of medical countermeasures and developed methods for pathogen identification and detection. Past projects included directing the development of informatics tools, developing institution-wide training programs for National Institutes of Health researchers, and participating in collaborative neurological disease research and customized data analysis with both clinical and basic science investigators.
Her research work has encompassed laboratory experiments as well as statistical and bioinformatic analysis of several important diseases and threats, including biodefense agents, Gaucher’s disease, multiple sclerosis, chronic fatigue syndrome and neurofibromatosis.
She has published 20 peer-reviewed journal articles, given numerous technical presentations and served as a reviewer on 15 government science and technology review panels.
Education
- Ph.D., Marine Biology and Biological Oceanography, University of Miami
- M.S., Marine Biology, University of Miami
- B.S., Microbiology, Cornell University